Indeed, brain permeable NtsR-1-specific agonists decrease feeding and body weight in normal mice, as well as in leptin-deficient obese mice, suggesting that Nts action via NtsR-1 may be useful in treating obesity (Feifel et al., 2010). This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.